Hydroxyalkyl piperazine derivatives used as CXCR3 receptor modulators

MA41337AUndetermined Publication Date: 2017-11-22IDORSIA PHARMACEUTICALS LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA41337
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2015-01-15
Filing Date: 2016-01-14
Publication Date: 2017-11-22

Application Information

Patent Timeline

15 Jan 2015

Priority

14 Jan 2016

Application

MA41337

22 Nov 2017

Publication

MA41337A

IPC: A61K31/427; A61P37/00; C07D417/14

CPC: C07D417/14; A61P25/28; A61P29/00; A61P31/00; A61P31/04; A61P35/00; A61P37/00; A61P37/02

Inventors: CAROFF Eva; MEYER Emmanuel

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to compounds of formula (i) in which n, x, r 1 and r 2 are as defined in the description; pharmaceutically acceptable salts thereof, and the use of such compounds as drugs, in particular as cxcr3 receptor modulators

Need to check novelty before this filing date? Find Prior Art